Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to XXXX ( @entity1067 ): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.

@entity1 @entity322 @entity1067 @entity397 @entity2754 @entity811
PURPOSE: To compare clinical and urodynamic results of transurethral resection of the prostate (TURP) to original and PErFecTED prostate artery embolization (PAE) methods for @entity1067 . METHODS: We prospectively randomized 30 @entity1 to receive TURP or original PAE (oPAE) and compared them to a cohort of @entity1 treated by PErFecTED PAE, with a minimum of 1-year follow-up. @entity1 were assessed for urodynamic parameters, prostate volume, international prostate symptom score (IPSS), and quality of life (QoL). RESULTS: All groups were comparable for all pre-treatment parameters except bladder contractility and peak urine flow rate (Q max), both of which were significantly better in the TURP group, and IIEF score, which was significantly higher among PErFecTED PAE @entity1 than TURP @entity1 . All groups experienced significant improvement in IPSS, QoL, prostate volume, and Q max. TURP and PErFecTED PAE both resulted in significantly lower IPSS than oPAE but were not significantly different from one another. TURP resulted in significantly higher Q max and significantly smaller prostate volume than either original or PErFecTED PAE but required spinal anesthesia and hospitalization. Two @entity1 in the oPAE group with hypocontractile bladders experienced recurrence of symptoms and were treated with TURP. In the TURP group, @entity322 occurred in 4/15 @entity1 (26.7 %), @entity397 of the prostatic capsule in 1/15 (6.7 %), @entity2754 in all @entity1 (100 %), and one @entity1 was readmitted for temporary bladder irrigation due to @entity811 . CONCLUSIONS: TURP and PAE are both safe and effective treatments. TURP and PErFecTED PAE yield similar symptom improvement, but TURP is associated with both better urodynamic results and more adverse events.
